ISRCTN ISRCTN20405426
DOI https://doi.org/10.1186/ISRCTN20405426
Secondary identifying numbers 945-14-217
Submission date
24/06/2005
Registration date
30/09/2005
Last edited
20/11/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Diederik W.J. Dippel
Scientific

PO Box 1738
Rotterdam
3000 DR
Netherlands

Phone +31 (0)10 4087979
Email d.dippel@erasmusmc.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymPRACTISE
Study objectives1. To evaluate the effect of a high intensity implementation strategy compared to a regular intensity strategy
2. Identify success factors and obstacles for implementation of thrombolysis
3. To assess the cost-effectiveness of thrombolysis in routine daily Dutch neurological care settings, taking into account the costs of implementation
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedStroke
InterventionThe high intensity intervention consists of the introduction of a set of implementation tools, directed at the four levels where barriers are expected. This toolkit will be explained in a training session to the vascular neurologist and coordinating nurse in each center, who also act as the local agents of change. Training session takes place after 6 months and 1 year.

Control: regular intensity strategy
Intervention typeOther
Primary outcome measureTreatment with thrombolysis or not in all registered patients
Secondary outcome measuresAdmission within 3 hours after onset of symptoms, death or disability at three months (in the subgroup of patients with ischemic stroke who were admitted within 3 hours).
Overall study start date01/08/2005
Completion date01/08/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants7,000
Key inclusion criteriaAll patients who are admitted with acute stroke i.e. patients with an acute focal neurological deficit, which cannot be explained by a condition other than stroke, and onset of symptoms not longer than 24 hours ago
Key exclusion criteriaAge under 18
Date of first enrolment01/08/2005
Date of final enrolment01/08/2007

Locations

Countries of recruitment

  • Netherlands

Study participating centre

PO Box 1738
Rotterdam
3000 DR
Netherlands

Sponsor information

Netherlands Organisation for Health Research and Development (ZonMw)
Research organisation

Laan van Nieuw Oost Indië 334
P.O. Box 93245
The Hague
2509 AE
Netherlands

Phone +31 (0)70 349 5111
Email info@zonmw.nl
Website http://www.zonmw.nl
ROR logo "ROR" https://ror.org/01yaj9a77

Funders

Funder type

Research organisation

Netherlands Organisation for Health Research and Development (ZonMw) (945-14-217)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/05/2007 Yes No
Results article results 01/09/2013 Yes No